Recommendations for intravenous immunoglobulin therapy of Kawasaki disease.
Shulman
S T
ST
Northwestern University Medical School, Chicago, IL.
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D009080:Mucocutaneous Lymph Node Syndrome / Q000628:therapy*
D016756:Immunoglobulins, Intravenous